KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Invested Capital (2018 - 2025)

Historic Invested Capital for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $698.4 million.

  • BioNTech SE's Invested Capital rose 16321.71% to $698.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 17746.55%. This contributed to the annual value of $1.5 billion for FY2024, which is 24526.66% up from last year.
  • Latest data reveals that BioNTech SE reported Invested Capital of $698.4 million as of Q3 2025, which was up 16321.71% from $164.1 million recorded in Q2 2025.
  • BioNTech SE's 5-year Invested Capital high stood at $15.5 billion for Q4 2021, and its period low was $157.2 million during Q2 2024.
  • In the last 5 years, BioNTech SE's Invested Capital had a median value of $466.4 million in 2025 and averaged $2.1 billion.
  • As far as peak fluctuations go, BioNTech SE's Invested Capital soared by 69148.43% in 2021, and later plummeted by 9830.46% in 2023.
  • Over the past 5 years, BioNTech SE's Invested Capital (Quarter) stood at $15.5 billion in 2021, then plummeted by 92.05% to $1.2 billion in 2022, then tumbled by 63.74% to $446.7 million in 2023, then skyrocketed by 245.27% to $1.5 billion in 2024, then crashed by 54.72% to $698.4 million in 2025.
  • Its last three reported values are $698.4 million in Q3 2025, $164.1 million for Q2 2025, and $466.4 million during Q1 2025.